Research and Practice in Thrombosis and Haemostasis · 2020 · 126 citations · 19 references
MedicineHematologyInfectious DiseasesHemostasisPulmonologyVirologyAnticoagulant TherapyAnticoagulation TherapyCoagulation AbnormalitiesCoagulation DisordersHemostatic DisordersThrombosisCoagulation HomeostasisCoagulation Scoring SystemsDiagnostic StagesLaboratory Diagnosis Of CoagulopathyMolecular Diagnostic MarkersProphylactic AnticoagulationTherapeutic AnticoagulationThrombotic Risk Assessment
Coronavirus disease 2019 (COVID-19) is associated with significant hypercoagulability. However, despite prophylactic anticoagulation, critically ill patients with this condition develop thromboses. This forum discusses the lungs as the epicenter for the hemostatic issues, puts forward a proposal for staging COVID-19 coagulopathy based on available diagnostic markers, and suggest considering current and future treatment options based on these different stages.
19
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
Tao Guo, Yongzhen Fan, Ming Chen et al. · JAMA Cardiology · 2020 · 4.3K citations · Full text